MX2016001012A - Imagenologia de una enfermedad neurologica. - Google Patents

Imagenologia de una enfermedad neurologica.

Info

Publication number
MX2016001012A
MX2016001012A MX2016001012A MX2016001012A MX2016001012A MX 2016001012 A MX2016001012 A MX 2016001012A MX 2016001012 A MX2016001012 A MX 2016001012A MX 2016001012 A MX2016001012 A MX 2016001012A MX 2016001012 A MX2016001012 A MX 2016001012A
Authority
MX
Mexico
Prior art keywords
imaging
imagenology
diagnosis
neurological disease
striatum
Prior art date
Application number
MX2016001012A
Other languages
English (en)
Spanish (es)
Inventor
Mark Joseph Rosser
Jan Wolber
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of MX2016001012A publication Critical patent/MX2016001012A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48Diagnostic techniques
    • A61B6/481Diagnostic techniques involving the use of contrast agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/501Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the head, e.g. neuroimaging or craniography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Dentistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nuclear Medicine (AREA)
  • Pulmonology (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
MX2016001012A 2013-07-25 2014-07-25 Imagenologia de una enfermedad neurologica. MX2016001012A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1313291.5A GB201313291D0 (en) 2013-07-25 2013-07-25 Imaging neurological disease
PCT/EP2014/066042 WO2015011267A1 (en) 2013-07-25 2014-07-25 Imaging neurological disease

Publications (1)

Publication Number Publication Date
MX2016001012A true MX2016001012A (es) 2016-05-09

Family

ID=49166921

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016001012A MX2016001012A (es) 2013-07-25 2014-07-25 Imagenologia de una enfermedad neurologica.

Country Status (16)

Country Link
US (1) US11051777B2 (https=)
EP (1) EP3024501B1 (https=)
JP (1) JP6590801B2 (https=)
KR (1) KR102340504B1 (https=)
CN (1) CN105392500B (https=)
AU (2) AU2014294983B2 (https=)
BR (1) BR112016001316B1 (https=)
CA (1) CA2916125A1 (https=)
DK (1) DK3024501T3 (https=)
ES (1) ES2722973T3 (https=)
GB (1) GB201313291D0 (https=)
IL (1) IL243383B (https=)
MX (1) MX2016001012A (https=)
RU (1) RU2015155792A (https=)
SG (1) SG11201600571RA (https=)
WO (1) WO2015011267A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104720840A (zh) * 2015-02-11 2015-06-24 清华大学深圳研究生院 基于多巴胺转运体显像特异性摄取比的半自动量化方法
TWI587841B (zh) * 2015-03-06 2017-06-21 國立陽明大學 定量分析核子醫學腦部影像的系統及方法
US20180000440A1 (en) * 2015-03-24 2018-01-04 Nihon Medi-Physics Co., Ltd. Image processing apparatus, image processing method, and program
KR101720288B1 (ko) 2016-05-11 2017-03-28 (주)바이오액츠 뇌 영상용 염료 및 이의 제조방법
JP6549521B2 (ja) * 2016-05-25 2019-07-24 富士フイルム富山化学株式会社 疾患鑑別支援装置及びコンピュータプログラム
TWI607739B (zh) * 2016-05-27 2017-12-11 許百靈 Spect多巴胺顯像定量分析技術與在腦多巴胺評估的用途
GB201621698D0 (en) * 2016-12-20 2017-02-01 Ge Healthcare Ltd (Ip) And Stichting Vumc And Acad Medical Center Differential Diagnosis
JP6995642B2 (ja) * 2018-01-19 2022-01-14 日本メジフィジックス株式会社 画像処理装置、画像処理方法およびプログラム
TWI686178B (zh) 2019-10-09 2020-03-01 中原大學 自動化定位核子醫學腦部影像紋狀體與計算紋狀體專一性攝取率的方法與系統
WO2021102323A1 (en) * 2019-11-21 2021-05-27 Likeminds, Inc. Pharmaceutical packaging units and methods for concomitant administration of radiotracers
PT4168409T (pt) 2021-03-22 2025-06-12 Neurocrine Biosciences Inc Inibidores de vmat2 e métodos de utilização
JP7834281B2 (ja) * 2022-02-18 2026-03-24 社会福祉法人兵庫県社会福祉事業団 画像処理プログラム、画像処理方法、および画像処理装置
CN119599879B (zh) * 2024-11-06 2025-10-24 复旦大学附属华山医院 一种基于深度学习的pet图像跨膜态合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009040727A2 (en) * 2007-09-26 2009-04-02 Philips Intellectual Property & Standards Gmbh Method of differentially diagnosing different types of dementia
US20100312105A1 (en) * 2007-10-31 2010-12-09 Alseres Pharmaceuticals, Inc. Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level
US8084018B2 (en) * 2007-10-31 2011-12-27 Alseres Pharmaceuticals, Inc. Methods for imaging dopamine transporter level

Also Published As

Publication number Publication date
KR20160037168A (ko) 2016-04-05
CN105392500A (zh) 2016-03-09
HK1222118A1 (zh) 2017-06-23
JP2016531903A (ja) 2016-10-13
US11051777B2 (en) 2021-07-06
CN105392500B (zh) 2023-08-18
GB201313291D0 (en) 2013-09-11
JP6590801B2 (ja) 2019-10-16
KR102340504B1 (ko) 2021-12-20
RU2015155792A3 (https=) 2018-05-23
AU2019253837B2 (en) 2021-11-25
BR112016001316B1 (pt) 2021-04-06
EP3024501A1 (en) 2016-06-01
CA2916125A1 (en) 2015-01-29
AU2019253837A1 (en) 2019-11-14
AU2014294983A1 (en) 2016-01-21
AU2014294983B2 (en) 2019-10-24
ES2722973T3 (es) 2019-08-20
IL243383B (en) 2018-07-31
SG11201600571RA (en) 2016-02-26
EP3024501B1 (en) 2019-03-27
RU2015155792A (ru) 2017-08-30
US20160183897A1 (en) 2016-06-30
DK3024501T3 (da) 2019-05-06
WO2015011267A1 (en) 2015-01-29

Similar Documents

Publication Publication Date Title
MX2016001012A (es) Imagenologia de una enfermedad neurologica.
IL285107A (en) Diagnostic, prognostic and therapeutic uses of long non-coding RNA molecules for heart diseases and rehabilitation medicine
ZA202107358B (en) Method for treating alzheimer's disease
HK1205453A1 (en) Methods of diagnosing and treating motor neuron diseases
MX375282B (es) Pirrolo[2,3-c]piridinas como agentes de formacion de imagenes para ovillos neurofibrilares.
CL2017000053A1 (es) Anticuerpos de unión a protofibrillas aß
BR112015012014A2 (pt) proteínas de ligação específicas duais penetrando a barreira hematoencefálica (bbb)
IL234101B (en) Compositions comprising acamprosate and baclofen for use in the treatment of parkinsonism
EP3088898A4 (en) Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents
WO2014178931A8 (en) Sobetirome in the treatment of myelination diseases
MX2018006247A (es) Metodos para tratar la enfermedad de alzheimer y trastornos relacionados.
EP3471625A4 (en) QUANTIFICATION OF MEDICAL ANATOMY: COMPUTER-ASSISTED DIAGNOSTIC TOOL
MX2018003893A (es) Moduladores del receptor p2x3 y p2x2/3 de diaminopirimidina para usarse en el tratamiento de la tos.
MX2015005948A (es) Polipeptidos para transporte de barrera hematoencefalica.
BR112013020265A2 (pt) formas de rifaximina e uso das mesmas
MX2015015907A (es) Metodo no invasivo objetivo para cuantificar el grado de comezon mediante el uso de mediciones psicofisiologicas.
JP2016519107A5 (https=)
BR112017005533A2 (pt) compostos e métodos
FR2979346B1 (fr) Nanocorps anti-vcam-1
CA2851761C (en) Method of diagnosis, prognostic or treatment of neurodegenerative diseases
EP2676665A4 (en) USE OF ALPHA-MANGOSTINE IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF ALZHEIMER
MY196981A (en) Compounds for imaging tau protein aggregates
PL3449009T3 (pl) Biomarkery mikroRNA we krwi do diagnozowania choroby Alzheimera
ECSP13012603A (es) Nueva formulacion del cetp(1)
CL2015001881A1 (es) Compuesto 4-hidroxi-2-metil-5-(propan-2-iliden)ciclohexil-3-en-1-carbaldehido; uso del compuesto para el tratamiento de la enfermedad de alzheimer; composición farmacéutica; método para preparar la composición.